Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by David MARTÍN-OLIVA
PARP Inhibition Sensitizes P53-Deficient Breast Cancer Cells to Doxorubicin-Induced Apoptosis
Biochemical Journal
Biochemistry
Cell Biology
Molecular Biology
Related publications
Reduced PAK1 Activity Sensitizes FA/BRCA-proficient Breast Cancer Cells to PARP Inhibition
Oncotarget
Oncology
PARP Inhibition Sensitizes Colorectal Cancer-Initiating Cells to Chemotherapy
Stem Cells
Medicine
Molecular Medicine
Developmental Biology
Cell Biology
Brca2Deficiency Sensitizes Cells to PARP Inhibition
Cancer Research
Cancer Research
Oncology
Sulfated Polysaccharide-Protein Complex Sensitizes Doxorubicin-Induced Apoptosis of Breast Cancer Cells in Vitro and in Vivo
Experimental and Therapeutic Medicine
Medicine
Cancer Research
Immunology
Microbiology
Magnetic Nanoparticles Sensitize McF-7 Breast Cancer Cells to Doxorubicin-Induced Apoptosis
World Journal of Surgical Oncology
Surgery
Oncology
Inhibition of Autophagy by Deguelin Sensitizes Pancreatic Cancer Cells to Doxorubicin
TAK1 Inhibitor 5z-7-Oxozeaenol Sensitizes Cervical Cancer to Doxorubicin-Induced Apoptosis
Oncotarget
Oncology
Inhibition of MEK/ERK1/2 Sensitizes Lymphoma Cells to Sorafenib-Induced Apoptosis
Leukemia Research
Cancer Research
Oncology
Hematology
Sulforaphane Sensitizes Human Breast Cancer Cells to Paclitaxel‑induced Apoptosis by Downregulating the NF‑κB Signaling Pathway
Oncology Letters
Cancer Research
Oncology